Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma

64Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Substantial effort has focused on the development of novel targeted agents for treating patients with late-stage colorectal carcinoma. These agents are designed specifically to inhibit biochemical processes associated with pathogenesis. Numerous molecules targeting the epidermal growth factor receptor have been investigated as therapeutic agents and appear to herald a shift in the treatment paradigm for colorectal carcinoma. © 2005 American Cancer Society.

Cite

CITATION STYLE

APA

Venook, A. P. (2005, June 15). Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma. Cancer. https://doi.org/10.1002/cncr.21123

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free